MeSH term
Frequency | Condition_Probility | Adolescent | 3 | 0.0 |
Amino Acid Substitution | 2 | 0.0 |
Aryldialkylphosphatase | 20 | 10.0 |
Child | 2 | 0.0 |
Cholesterol/blood | 2 | 0.0 |
Esterases/*genetics | 14 | 18.0 |
Female | 20 | 0.0 |
Genetic Predisposition to Disease | 5 | 0.0 |
Genotype | 23 | 0.0 |
Humans | 39 | 0.0 |
Male | 23 | 0.0 |
*Multigene Family | 3 | 0.0 |
Risk Factors | 10 | 0.0 |
Alleles | 12 | 0.0 |
Aryldialkylphosphatase/*genetics | 8 | 32.0 |
Chi-Square Distribution | 2 | 0.0 |
Chromosomes, Human, Pair 7 | 2 | 1.0 |
Haplotypes | 4 | 0.0 |
Polymerase Chain Reaction | 4 | 0.0 |
*Variation (Genetics) | 6 | 0.0 |
Aged | 7 | 0.0 |
Aged, 80 and over | 4 | 0.0 |
*Aryldialkylphosphatase | 6 | 100.0 |
Case-Control Studies | 5 | 0.0 |
Codon/genetics | 2 | 0.0 |
Gene Frequency | 9 | 0.0 |
Middle Aged | 15 | 0.0 |
Multigene Family | 3 | 0.0 |
*Mutation, Missense | 2 | 0.0 |
Research Support, Non-U.S. Gov't | 28 | 0.0 |
Adult | 13 | 0.0 |
Lipoproteins, HDL Cholesterol/blood | 2 | 0.0 |
Polymorphism, Genetic | 7 | 0.0 |
Reference Values | 2 | 0.0 |
Risk | 2 | 0.0 |
Regression Analysis | 3 | 0.0 |
Blotting, Western | 2 | 0.0 |
Cells, Cultured | 2 | 0.0 |
Cloning, Molecular | 3 | 0.0 |
Endothelium, Vascular/metabolism | 2 | 0.0 |
Hela Cells | 2 | 0.0 |
Lipoproteins, HDL/metabolism | 3 | 2.0 |
Lipoproteins, LDL/*metabolism | 2 | 1.0 |
Oxidative Stress | 3 | 0.0 |
Research Support, U.S. Gov't, P.H.S. | 10 | 0.0 |
Time Factors | 2 | 0.0 |
Tissue Distribution | 2 | 0.0 |
Animals | 10 | 0.0 |
Rats | 2 | 0.0 |
Rats, Wistar | 2 | 0.0 |
Infant, Newborn | 5 | 0.0 |
Phenotype | 8 | 0.0 |
Polymorphism, Genetic/*genetics | 5 | 0.0 |
Lipoproteins, LDL/metabolism | 2 | 0.0 |
Mice | 6 | 0.0 |
Oxidation-Reduction | 2 | 0.0 |
Lipids/blood | 2 | 0.0 |
Canada | 2 | 1.0 |
Linkage Disequilibrium | 3 | 0.0 |
*Polymorphism, Genetic | 9 | 0.0 |
*Genetic Predisposition to Disease | 3 | 0.0 |
Metabolic Detoxication, Drug/genetics | 2 | 10.0 |
Amino Acid Sequence | 4 | 0.0 |
Base Sequence | 5 | 0.0 |
Lipid Peroxidation | 2 | 1.0 |
Molecular Sequence Data | 4 | 0.0 |
Rabbits | 2 | 0.0 |
Comparative Study | 6 | 0.0 |
Logistic Models | 4 | 0.0 |
China/epidemiology | 2 | 1.0 |
Pregnancy | 2 | 0.0 |
Cardiovascular Diseases/*physiopathology | 2 | 18.0 |
Lipoproteins/*blood | 2 | 0.0 |
Diet | 2 | 0.0 |
Smoking | 3 | 0.0 |
Chromosome Mapping | 3 | 0.0 |
Sequence Alignment | 2 | 0.0 |
Sequence Homology, Amino Acid | 2 | 0.0 |
*Chromosomes, Human, Pair 7 | 3 | 1.0 |
Analysis of Variance | 2 | 0.0 |
Coronary Disease/enzymology/epidemiology/*genetics | 2 | 40.0 |
Esterases/*genetics/metabolism | 2 | 50.0 |
European Continental Ancestry Group | 2 | 0.0 |
Genetic Heterogeneity | 2 | 0.0 |
DNA Primers | 2 | 0.0 |
Mice, Inbred BALB C | 2 | 0.0 |
Linkage Disequilibrium/genetics | 2 | 1.0 |
Asian Continental Ancestry Group/*genetics | 2 | 0.0 |
Cytochrome P-450 CYP2E1/*genetics | 2 | 1.0 |
DNA/genetics/metabolism | 2 | 0.0 |
English Abstract | 2 | 0.0 |
Infant, Premature/*metabolism | 2 | 10.0 |
Questionnaires | 2 | 0.0 |
